Agape Net Income From Continuing Ops from 2010 to 2026
| ATPC Stock | 3.78 1.76 87.13% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -2.2 M | Current Value -2.3 M | Quarterly Volatility 1.3 M |
Financial statement trends for Agape ATP provide structured context on operating performance and capital structure. Track Depreciation And Amortization of 234.2 K, Selling General Administrative of 3.8 M or Other Operating Expenses of 2.4 M and ratios such as Price To Sales Ratio of 61.87, Dividend Yield of 0.0 or PTB Ratio of 36.63 to align performance context with Agape ATP Valuation and Volatility.
Agape | Net Income From Continuing Ops | Build AI portfolio with Agape Stock |
Analyzing Agape ATP's Net Income From Continuing Ops over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income From Continuing Ops has evolved provides context for assessing Agape ATP's current valuation and future prospects.
Latest Agape ATP's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Agape ATP over the last few years. It is Agape ATP's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Agape ATP's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Agape Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | -542,498 | |
| Geometric Mean | 671,455 | |
| Coefficient Of Variation | -233.63 | |
| Mean Deviation | 1,161,165 | |
| Median | 354,766 | |
| Standard Deviation | 1,267,416 | |
| Sample Variance | 1.6T | |
| Range | 2.9M | |
| R-Value | -0.83 | |
| Mean Square Error | 543.3B | |
| R-Squared | 0.68 | |
| Significance | 0.000043 | |
| Slope | -207,415 | |
| Total Sum of Squares | 25.7T |
Agape Net Income From Continuing Ops History
Agape ATP Valuation Analysis
Agape ATP is a micro-cap equity in Health Care Providers & Services, Health Care Equipment & Services, Consumer Defensive categories. Growth expectations are weighed against macro conditions. Market-sensitive characteristics amplify cycle exposure. This analysis reviews how Agape ATP integrates into a multi-asset portfolio across market cycles.
Methodology
Unless otherwise specified, financial data for Agape ATP is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Agape (USA Stocks:ATPC) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Valuation estimates and intrinsic-value models use inputs from public financial disclosures and may not represent market consensus.
Assumptions
We primarily rely on public filings and market reference sources, including disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data is normalized for analytical consistency across reporting formats. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.Analyst Sources
Agape ATP may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.More Resources for Agape Stock Analysis
Reviewing Agape ATP commonly begins with financial statements and performance trends. Key ratios help frame profitability, efficiency, and growth context for Agape Atp Stock. Below are reports that help frame Agape Atp Stock in context:Agape ATP Correlation provides competitor comparison context for Agape ATP. The view adds relative comparison context. Learn how to buy and trade Agape Stock using our step-by-step How to Buy Agape ATP guide.Analysis related to Agape ATP should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Earnings Share -12.50 | Revenue Per Share | Quarterly Revenue Growth 0.119 | Return On Assets | Return On Equity |
Understanding Agape ATP includes distinguishing between market value and book value, where book value reflects Agape accounting equity. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Market price responds to sentiment, liquidity, and macro shifts, so gaps can appear. Valuation work aligns these measures into a single context.
The concept of value for Agape ATP differs from its quoted price, since each reflects a different lens. Context can include financial performance, operating efficiency, market trends, and peer comparisons. By contrast, market price reflects the level where buyers and sellers transact.